Physician profile
Inja Kim
NPI 1588762769
$11,003.47
in general payments reported to CMS, 2019-2025
32 companies · $1,060 in 2025
The $1,060 reported for 2025 was more than what 79% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,972 · 2020: $398 · 2021: $1,858 · 2022: $1,969 · 2023: $782 · 2024: $965 · 2025: $1,060.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,787 · Entertainment: $19.71.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,787.25 |
| Entertainment | $19.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,439.34 | 2019-2025 | Clareon, Voyager Dslt, Hydrus Microstent |
| Bausch & Lomb Americas INC. | $1,265.27 | 2022-2025 | Vyzulta, Miebo, Xiidra |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $1,002.29 | 2019-2021 | |
| Oyster Point Pharma, INC. | $974.29 | 2022-2025 | Tyrvaya, Ryzumvi |
| Kala Pharmaceuticals, INC. | $551.59 | 2019-2022 | |
| Sun Pharmaceutical Industries INC. | $539.29 | 2019-2025 | |
| Allergan, INC. | $515.12 | 2019-2022 | |
| Aerie Pharmaceuticals, INC. | $479.24 | 2019-2021 | |
| Sight Sciences, INC. | $373.93 | 2020-2022 | |
| Dompe US, INC. | $350.91 | 2021-2024 | Oxervate |
| Beaver-Visitec International, INC. | $310.22 | 2021-2022 | |
| Ivantis, INC | $276.93 | 2019 | |
| Shire North American Group INC | $237.50 | 2019 | |
| Eyevance Pharmaceuticals LLC | $180.09 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $179.26 | 2019 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ani Pharmaceuticals, INC. | $177.13 | 2025 | Purified Cortrophin Gel |
| New World Medical,INC. | $175.40 | 2019-2023 | |
| Abbvie INC. | $157.89 | 2022-2024 | |
| Rxsight INC | $151.84 | 2023-2024 | Rxsight Injector Cartridge, Rxsight Contact Lens, Rxsight Injector Handpiece |
| Galderma Laboratories, L.P. | $124.99 | 2024 | |
| Mallinckrodt Hospital Products INC. | $120.26 | 2021 | |
| Johnson & Johnson Surgical Vision, INC. | $87.97 | 2025 | Tecnis Simplicity |
| Horizon Therapeutics Plc | $77.49 | 2021-2022 | |
| Merz Pharmaceuticals, LLC | $40.61 | 2025 | Xeomin |
| Carl Zeiss Meditec Ag | $38.80 | 2020 | |
| Harrow Eye, LLC | $37.02 | 2025 | Vevye |
| Tarsus Pharmaceuticals, INC. | $34.46 | 2025 | Xdemvy |
| Astellas Pharma US INC | $30.09 | 2024 | Izervay |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $20.61 | 2021 | |
| Optos, INC. | $19.71 | 2023 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Eyepoint US, INC. | $18.62 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $15.31 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Inja Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.